Filter Results:
(454)
Show Results For
- All HBS Web
(1,902)
- Faculty Publications (454)
Show Results For
- All HBS Web
(1,902)
- Faculty Publications (454)
Page 1 of 454
Results →
- September 2024
- Supplement
National Public Broadcasting (B)
By: Richard S. Ruback and Royce Yudkoff
Pre-abstract: Instructors should consider the timing of making videos available to students, as they may reveal key case details.
Abstract: This (B) case supplement is designed for use by faculty only to support classroom instruction in conjunction with "National... View Details
Keywords: Financial Strategy; Financial Management; Media; Ownership; Strategy; Advertising; Decision Making; Entrepreneurship; Financing and Loans; Mergers and Acquisitions; Private Equity; Journalism and News Industry; Media and Broadcasting Industry; United States
Ruback, Richard S., and Royce Yudkoff. "National Public Broadcasting (B)." Harvard Business School Multimedia/Video Supplement 225-706, September 2024.
- September 2024 (Revised October 2024)
- Case
River Remedy: Navigating Mississippi’s Medical Marijuana Market
By: Robin Greenwood, Richard S. Ruback and Robert Ialenti
MBA student William Chism, the founder of a fully integrated medical marijuana company based in Mississippi, must respond to a significant disruption in the fledgling industry. In late 2023, Rapid Analytics, one of two active licensed testing facilities, has its... View Details
Keywords: Plant-Based Agribusiness; Business Growth and Maturation; Forecasting and Prediction; Microeconomics; Local Range; Government Legislation; Demand and Consumers; Supply and Industry; Competition; Competitive Strategy; Agriculture and Agribusiness Industry; Consumer Products Industry; Mississippi
Greenwood, Robin, Richard S. Ruback, and Robert Ialenti. "River Remedy: Navigating Mississippi’s Medical Marijuana Market." Harvard Business School Case 225-011, September 2024. (Revised October 2024.)
- 2024
- White Paper
Modernizing the U.S. Exchange Visitor Skills List
By: William R. Kerr and Michael C. Clemens
Kerr, William R., and Michael C. Clemens. "Modernizing the U.S. Exchange Visitor Skills List." Peterson Institute for International Economics Policy Brief, 24-8, Peterson Institute for International Economics, September 2024.
- August 2024
- Case
Sky Therapeutics: Innovating in Digital Therapeutics
By: Satish Tadikonda, Olivia Reszczynski and William Marks
Shad Faraz and Alex Youssef were intrigued by the opportunities in the relatively new area of Digital Therapeutics. Despite initial successes, early entrants had struggled with reimbursement and revenue-predictability challenges. However, venture investors still... View Details
- July 2024
- Case
Gates Ventures: Making Alzheimer's a Forgotten Past
By: Satish Tadikonda, William Marks, Shardule Shah and Calvin Marambo
After a personal journey and interest in Alzheimer's Disease (AD) by Bill Gates, Gates Ventures set out to find the best way to accelerate innovation in the field of AD. In partnership with the Alzheimer's Drug Discovery Foundation, Gates Ventures created the... View Details
Tadikonda, Satish, William Marks, Shardule Shah, and Calvin Marambo. "Gates Ventures: Making Alzheimer's a Forgotten Past." Harvard Business School Case 824-075, July 2024.
- July 2024
- Article
JUE Insight: Infrastructure and Finance: Evidence from India's GQ Highway Network
By: Abhiman Das, Ejaz Ghani, Arti Grover, William Kerr and Ramana Nanda
We use data from Reserve Bank of India to study the impact of India's Golden Quadrilateral (GQ) highway project on finance-dependent activity. Loan volumes increase by 20-30% in districts along GQ and are stronger in industries more dependent upon external finance.... View Details
Keywords: Highways; Finance; Development; Infrastructure; Banks and Banking; Transportation Networks; Financing and Loans; Growth and Development; India
Das, Abhiman, Ejaz Ghani, Arti Grover, William Kerr, and Ramana Nanda. "JUE Insight: Infrastructure and Finance: Evidence from India's GQ Highway Network." Art. 103593. Journal of Urban Economics 142 (July 2024).
- 2024
- Working Paper
Immigrant Entrepreneurship: New Estimates and a Research Agenda
By: Saheel Chodavadia, Sari Pekkala Kerr, William R. Kerr and Louis Maiden
Immigrants contribute disproportionately to entrepreneurship in many countries, accounting for a quarter of new employer businesses in the US. We review recent research on the measurement of immigrant entrepreneurship, the traits of immigrant founders, their economic... View Details
Keywords: Immigrant Employment; Immigration; Entrepreneurship; Demographics; Innovation and Invention
Chodavadia, Saheel, Sari Pekkala Kerr, William R. Kerr, and Louis Maiden. "Immigrant Entrepreneurship: New Estimates and a Research Agenda." Harvard Business School Working Paper, No. 24-068, April 2024.
- March 2024
- Supplement
Miracle Therapeutics (B)
By: Satish Tadikonda, William Marks and Wendi Yajnik
Supplements the (A) case. Following on the negotiations detailed in the Miracle Therapeutics (A) case, Beth Sharp and Jennifer Brilliant from Miracle Therapeutics face new challenges with their company's funding and intellectual property (IP) after several missteps.... View Details
Keywords: Business Startups; Financing and Loans; Intellectual Property; Problems and Challenges; Business or Company Management
Tadikonda, Satish, William Marks, and Wendi Yajnik. "Miracle Therapeutics (B)." Harvard Business School Supplement 824-044, March 2024.
- February 2024
- Case
Chime Solutions
Just two years after launching its 10k by 2020 initiative to hire 10,000 employees by 2020, the COVID-19 pandemic forced Chief Executive Officer Mark Wilson to send nearly all of his staff at Chime Solutions (Chime) to work from home. Chime was a customer contact firm... View Details
Keywords: Working Capital; Service Operations; Recruitment; Performance; Change Management; Retention; Financial Institutions; Employee Relationship Management; Talent and Talent Management; Growth Management; Mission and Purpose; Communications Industry; Service Industry; United States
Bernstein, Shai, William R. Kerr, Christopher Stanton, Raymond Kluender, and Mel Martin. "Chime Solutions." Harvard Business School Case 824-133, February 2024.
- February 2024
- Article
Representation and Extrapolation: Evidence from Clinical Trials
By: Marcella Alsan, Maya Durvasula, Harsh Gupta, Joshua Schwartzstein and Heidi L. Williams
This article examines the consequences and causes of low enrollment of Black patients in clinical
trials. We develop a simple model of similarity-based extrapolation that predicts that evidence is
more relevant for decision-making by physicians and patients when it... View Details
Keywords: Representation; Racial Disparity; Health Testing and Trials; Race; Equality and Inequality; Innovation and Invention; Pharmaceutical Industry
Alsan, Marcella, Maya Durvasula, Harsh Gupta, Joshua Schwartzstein, and Heidi L. Williams. "Representation and Extrapolation: Evidence from Clinical Trials." Quarterly Journal of Economics 139, no. 1 (February 2024): 575–635.
- 2024
- Working Paper
Age at Immigrant Arrival and Career Mobility: Evidence from Vietnamese Refugee Migration and the Amerasian Homecoming Act
By: Sari Pekkala Kerr, William R. Kerr and Kendall Smith
We study the long-run career mobility of young immigrants, mostly refugees, from Vietnam who moved to the United States during 1989-1995. This third and final migration wave of young Vietnamese immigrants was sparked by unexpected events that culminated in the... View Details
Keywords: Vietnam; Vietnam War; Assimilation; Immigration; Refugees; Age; Outcome or Result; Personal Development and Career; Viet Nam
Kerr, Sari Pekkala, William R. Kerr, and Kendall Smith. "Age at Immigrant Arrival and Career Mobility: Evidence from Vietnamese Refugee Migration and the Amerasian Homecoming Act." Harvard Business School Working Paper, No. 24-044, January 2024.
- 2024
- Working Paper
The Wandering Scholars: Understanding the Heterogeneity of University Commercialization
By: Josh Lerner, Henry Manley, Carolyn Stein and Heidi Williams
University-based scientific research has long been argued to be a central source of
commercial innovation and economic growth. Yet at the same time, there have been
long-held concerns that many university-based discoveries never realize their potential
social... View Details
Lerner, Josh, Henry Manley, Carolyn Stein, and Heidi Williams. "The Wandering Scholars: Understanding the Heterogeneity of University Commercialization." Harvard Business School Working Paper, No. 24-043, January 2024.
- January 2024
- Case
Huawei: Resilience amid Autarky and Adversity
By: William C. Kirby and Daniel Fu
In September 2023, Huawei made a dramatic return to the global smartphone space with the launch of its Mate 60 Pro smartphone, equipped with an indigenously designed, 7nm chip. This came despite a myriad of export controls and restrictions imposed against the company... View Details
Keywords: International Strategy; Semiconductors; Smartphone; Government And Politics; Government And Business; Digital Infrastructure; 5G; Political Risk; Business and Government Relations; Global Strategy; Multinational Firms and Management; Governing Rules, Regulations, and Reforms; AI and Machine Learning; Mobile and Wireless Technology; Leadership; Retirement; Corporate Strategy; Technology Industry; China; United States; Europe; Asia; Middle East
- January 2024
- Article
Cost of Exempting Sole Orphan Drugs from Medicare Negotiation
By: Matthew Vogel, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim and Benjamin N. Rome
Importance: The Inflation Reduction Act (IRA) requires Medicare to negotiate prices for some high-spending drugs but exempts drugs approved solely for the treatment of a single rare disease.
Objective: To estimate Medicare spending and global... View Details
Objective: To estimate Medicare spending and global... View Details
Vogel, Matthew, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim, and Benjamin N. Rome. "Cost of Exempting Sole Orphan Drugs from Medicare Negotiation." JAMA Internal Medicine 184, no. 1 (January 2024): 63–69.
- November 2023
- Case
Swanson Health: Becoming a Super Seller
By: William R. Kerr, Daniel O'Connor and Paige Boehmcke
Founded in 1969, Swanson Health sold vitamins, supplements, natural health products, and organic foods. Over the years, the company had successfully navigated multiple industry transitions as it expanded from a print catalog to sell products on its own... View Details
Keywords: Sales; Transition; Growth Management; Distribution Channels; Organizational Change and Adaptation; Health Industry; Consumer Products Industry; United States
Kerr, William R., Daniel O'Connor, and Paige Boehmcke. "Swanson Health: Becoming a Super Seller." Harvard Business School Case 824-093, November 2023.
- November 2023
- Case
Will Fintechs and Central Banks Play in Emtech's Sandbox?
By: Daniel Isenberg and William R. Kerr
In February 2023, Emtech’s founder Carmelle Cadet is facing a dilemma. Rapidly running out of cash, Cadet has a term sheet from a leading VC but has a choice of how to structure the investment. The decision will have significant implications for Cadet’s own stake, as... View Details
Keywords: Cryptocurrency; Business Startups; Venture Capital; Cash Flow; Currency; Governing Rules, Regulations, and Reforms; Digital Platforms
Isenberg, Daniel, and William R. Kerr. "Will Fintechs and Central Banks Play in Emtech's Sandbox?" Harvard Business School Case 824-096, November 2023.
- November 2023 (Revised April 2024)
- Case
Khanmigo: Revolutionizing Learning with GenAI
By: William A. Sahlman, Allison M. Ciechanover and Emily Grandjean
Already a leader in the edtech space since its 2008 launch, Khan Academy was now one of the first edtech organizations to embrace generative artificial intelligence ("genAI"). In March 2023, Khan Academy began beta testing Khanmigo, a genAI “guide” and tutor built with... View Details
Keywords: Technology Adoption; Leading Change; Entrepreneurship; Risk and Uncertainty; Education; AI and Machine Learning; Corporate Social Responsibility and Impact; Education Industry; Technology Industry; United States; San Francisco
Sahlman, William A., Allison M. Ciechanover, and Emily Grandjean. "Khanmigo: Revolutionizing Learning with GenAI." Harvard Business School Case 824-059, November 2023. (Revised April 2024.)
- October 2023 (Revised April 2024)
- Case
TetraScience: Unlocking the Power of Scientific Data
By: Satish Tadikonda and William Marks
After pivoting from a focus on hardware to a focus on scientific data, TetraScience, led by veteran SaaS executive, Patrick Grady and Founder Spin Wang, has embarked on a journey from nearly cash-out to a player in the scientific data management space. This case... View Details
Keywords: Business Model; Change Management; Entrepreneurship; Information Management; Business Strategy; Market Entry and Exit; Information Technology Industry
Tadikonda, Satish, and William Marks. "TetraScience: Unlocking the Power of Scientific Data." Harvard Business School Case 824-072, October 2023. (Revised April 2024.)
- October 2023 (Revised June 2024)
- Case
Catalent: Catalyzing the Next Era of Growth
By: Satish Tadikonda, William Marks and Kevin Emancipator
Catalent's newly appointed CEO, Alessandro Maselli, experienced the highs of the pharmaceutical contract development manufacturing (CDMO) space during COVID-19 while helping Moderna and others bring vaccines to market quickly and safely. After rushing to add capacity... View Details
Keywords: Leadership; Business or Company Management; Organizational Change and Adaptation; Pharmaceutical Industry
Tadikonda, Satish, William Marks, and Kevin Emancipator. "Catalent: Catalyzing the Next Era of Growth." Harvard Business School Case 824-016, October 2023. (Revised June 2024.)
- October 2023
- Case
Vida Health: Transforming Chronic Disease Treatment
By: William Sahlman and Nicole Tempest Keller
San Francisco based Vida Health, founded by Stephanie Tilenius, former vice president of Commerce and Payments at Google, was a B2B digital health startup focused on the treatment of cardiometabolic conditions, such as diabetes and obesity. Its innovative digital... View Details
Keywords: Corporate Strategy; Growth and Development Strategy; Demand and Consumers; Health Care and Treatment; Product Marketing; Risk and Uncertainty; Technological Innovation; Health Industry; Technology Industry; United States; California; San Francisco
Sahlman, William, and Nicole Tempest Keller. "Vida Health: Transforming Chronic Disease Treatment." Harvard Business School Case 824-001, October 2023.